Cemiplimab for Orbital Squamous Cell Carcinoma in 11 Cases.

Ophthalmic Plast Reconstr Surg

Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven.

Published: September 2022

Purpose: To review the demographics, clinical features, and response of orbital squamous cell carcinoma treated with cemiplimab.

Methods: This is a retrospective multi-institutional series. Patient characteristics, drug dosing, duration, and response to treatment were evaluated.

Results: The study cohort consisted of 11 patients from 5 institutions. All patients received a regimen of 350 mg q 3 weeks and an average of 11.2 cycles (SD 5.8). No patient experienced significant side effects requiring treatment or cessation of cemiplimab. Complete response was achieved in 9 patients (82%) treated with cemiplimab.

Conclusions: Immune checkpoint inhibitors, such as cemiplimab provide a globe-sparing option for the treatment of orbital squamous cell carcinoma. It is important to consider these agents especially when orbital exenteration is the alternative.

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000002190DOI Listing

Publication Analysis

Top Keywords

orbital squamous
12
squamous cell
12
cell carcinoma
12
cemiplimab orbital
4
carcinoma cases
4
cases purpose
4
purpose review
4
review demographics
4
demographics clinical
4
clinical features
4

Similar Publications

Proton Beam Therapy for Advanced Periocular Skin Cancer: An Eye-Sparing Approach.

Cancers (Basel)

January 2025

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Cox 308, Boston, MA 02114, USA.

The management of periocular skin malignancies presents a unique challenge. Proton beam therapy, due to its sharp dose fall-off, allows for the delivery of a tumoricidal dose to the tumor while sparing adjacent normal tissues. Thirteen patients with a median age of 76.

View Article and Find Full Text PDF

Background: Rathke cleft cysts (RCCs) are benign sellar/suprasellar lesions that result from mucin-secreting vestigial remnants within the pars intermedia of the pituitary gland. When symptomatic, they can present with retro-orbital headaches, visual field defects, and/or pituitary dysfunction.

Observations: A 35-year-old female presented with subacute retro-orbital headache, right ptosis, and blurred vision.

View Article and Find Full Text PDF

Inverted papilloma is a rare, benign epithelial tumor of the nasal and sinus cavities with an unclear etiology. It usually presents as unilateral nasal obstruction. Diagnosis is histological, and treatment is primarily surgical.

View Article and Find Full Text PDF

Background: Locally advanced periorbital cutaneous squamous cell carcinoma (cSCC) may require orbital exenteration, which is highly morbid. As immunotherapy develops, orbit preservation may become widespread, and data benchmarking survival with current standard-of-care surgery and radiotherapy are essential to the integration of this emerging method into modern treatment paradigms. This study aimed to determine the survival of patients after orbital exenteration for cSCC and investigate contributing factors.

View Article and Find Full Text PDF

Purpose: The purpose of this manuscript is to report a rare case of an orbital cyst detected intrauterine with sonography.

Observation: A 23-year-old female presented for routine prenatal monitoring when an orbital cyst was detected with a transabdominal ultrasound. Uncomplicated cesarean section was performed at 38 weeks gestation with proptosis of the left globe being noted on ophthalmic examination of the newborn.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!